樂觀
$38.45
情境價格
$31.290
0.000 (0.00%)收盤時
Option Care Health, Inc. is an independent provider of home and alternate site infusion services. Its infusion services include the clinical management of infusion therapy, nursing support and care coordination. It provides a therapy portfolio through its network of over 87 full-service pharmacies and 109 stand-alone ambulatory infusion suites. It administers a wide variety of therapies and services, including anti-infectives infusion, nutrition support, immunoglobulin infusion, chronic inflammatory disorders, neurological disorders, bleeding disorders infusion, Naven health, women's health, heart failure, and others. Its home infusion services include medication and supplies for administration and use at home or within one of its ambulatory infusion suites, consultation and education regarding the patient's condition and the prescribed medication nursing support, clinical monitoring and assistance in monitoring potential side effects, and assistance in obtaining reimbursement.
Option Care Health Inc is currently priced at $31.22, which is close to the acquisition price of $32.05 set by McKesson and CD&R. The RSI is at 83.77, indicating it is overbought, which suggests caution for new buyers. The stock has seen a significant 35.33% increase over the last 20 days, but the recent downgrades from analysts suggest that the stock may not have much upside left in the short term. The main risk is the potential for regulatory hurdles or shareholder disapproval regarding the acquisition, which could impact the stock's price negatively.
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

Investor Rights Law Firm Investigates Multiple Companies

Investor Rights Law Firm Investigates Multiple Companies for Potential Violations

Investor Rights Law Firm Investigates Multiple Companies

Investigation into Option Care Health Acquisition Fairness

Option Care Health Shares Surge on Acquisition News
Option Care Health, Inc. is an independent provider of home and alternate site infusion services. Its infusion services include the clinical management of infusion therapy, nursing support and care coordination. It provides a therapy portfolio through its network of over 87 full-service pharmacies and 109 stand-alone ambulatory infusion suites. It administers a wide variety of therapies and services, including anti-infectives infusion, nutrition support, immunoglobulin infusion, chronic inflammatory disorders, neurological disorders, bleeding disorders infusion, Naven health, women's health, heart failure, and others. Its home infusion services include medication and supplies for administration and use at home or within one of its ambulatory infusion suites, consultation and education regarding the patient's condition and the prescribed medication nursing support, clinical monitoring and assistance in monitoring potential side effects, and assistance in obtaining reimbursement. It operates in the Healthcare sector (SERVICES-HOME HEALTH CARE SERVICES industry).
Option Care Health Inc is currently priced at $31.22, which is close to the acquisition price of $32.05 set by McKesson and CD&R. The RSI is at 83.77, indicating it is overbought, which suggests caution for new buyers. The stock has seen a significant 35.33% increase over the last 20 days, but the recent downgrades from analysts suggest that the stock may not have much upside left in the short term. The main risk is the potential for regulatory hurdles or shareholder disapproval regarding the acquisition, which could impact the stock's price negatively.
暫無貼文
註冊或登入後參與討論本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。